Accelerating Belgian health-tech & biopharma innovation

iStock-1093656424-web5

See what’s happening in Wallonia, Belgium

Latest news & events

Learn more
BioWin COO

BioWin strengthens focus on advanced therapies and nuclear medicine

    Corporate

14.02.2025

Learn more
Biowin-new-identity

BioWin launches new website, refreshes visual identity

    Corporate

28.01.2025

Learn more
Indianapolis-1872528

Sign up for AWEX and BioWin’s nuclear medicine mission this spring in the U.S. and Canada

    International Mission

08.01.2025

Learn more
getty-images-OPu3FqYgz5A-unsplash

Call 45 for collaborative R&D projects is open: Wallonia & Flanders team up for innovation!

    Funding Open calls

08.01.2025

Learn more
Science-for-health-website-post-thumbnail

Science for Health 2024: from innovation to implementation of AI and digitalisation in healthcare

    Press release

12.11.2024

Learn more

Annual Report 2023

    Corporate

03.07.2024

Learn more
getty-images-XMx3Ata6UMA-unsplash

White Raven, a new Belgian CDMO, obtains GMP certification for its aseptic fill & finish facility with a robotic gloveless workcell for small-batch manufacturing

    Press release

11.03.2025

Learn more
4tissue

4Tissue secures an additional €1.5M in funding and appoints Dr. Katleen Verleysen as independent chair of the board

    Press release

26.02.2025

Learn more
1740554905779

IBA and Jabil sign contract to install a Be-Wide X-ray solution in Mississippi, USA

    Press release

25.02.2025

Learn more

Hyloris Announces FDA Acceptance of New Drug Application (NDA) for Valacyclovir Oral Liquid

    Press release

25.02.2025

Learn more
Adobe-Express-file-1

Synergia Medical announces strong results for NAO.VNS™ first-in-human study

    Press release

24.02.2025

Learn more

Novadip shares positive 12-month results from phase 1b/2a trial with NVDX3 in trauma

    Press release

20.02.2025

Stay informed with the BioWin newsletter

Innovate

Why join BioWin

We help simplify the path to bringing innovative ideas to life. With nearly 20 years of hands-on collaborative innovation experience, we don’t just connect companies, research centers, hospitals, and academic institutions—we’re a true partner, offering real support at every step of the research and development process.

From shaping your project to sourcing its financing and ensuring it stays on track, that’s how we give health-tech and biopharma innovations their greatest chance of success.

iStock-542576976

Connect

Why join BioWin

In a bid to increase opportunities for our members in terms of both collaboration and market expansion, we connect them to partners through regular events. We also seek to enhance sector attractiveness to source the future talent needed to create sustainable innovation across the Walloon Region.

 

iStock-530685719

Communicate

Why join BioWin

Our targeted communication strategies aim to strengthen Wallonia’s profile, while maximising our members’ presence both locally and globally.

getty-images-B1n_PGHf4JA-unsplash

Operating at the epicentre of regional health-tech & biopharma innovation

What we work on

Biopharma

iStock-1289345741

Health-tech

iStock-1125084447-web
  • From championing collaborative innovation to playing a more global role in the implementation of the sector’s industrial policy, making innovation happen is part of our DNA.
  • We aim to increase the competitiveness of the Walloon region in the biopharma and health-tech sectors by identifying and supporting strategic projects and portfolios for the benefit of our members and the patients they serve.
  • BioWin’s network of 260+ world-class organisations is an exceptional ecosystem known for both its academic excellence and robust industrial value chain in biomanufacturing, advanced therapies, nuclear medicine and medical technologies. 

Our ecosystem at a glance

Numbers

257

supported organisations

89

supported R&D projects

313,74M

€ raised by our members through public-private funding

5

job offers